-
公开(公告)号:US20180221182A1
公开(公告)日:2018-08-09
申请号:US15835418
申请日:2017-12-07
Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Inventor: Daniel H. Shumer , Ronald G. Earles , Nianjiong J. Bei , Barbara Stamberg , Daniel Simon , Maria Del Rosario Nava , Michael L. Green , Matthew J. Gillick
CPC classification number: A61F2/966 , A61F2002/9517 , A61F2210/0076 , A61F2250/0098 , F16H19/025 , F16H19/04 , F16H31/007
Abstract: A system for delivering an implant including a handle, a trigger, an actuation assembly, and a catheter assembly. The actuation assembly is configured to displace the outer tubular member in the proximal direction and to separately move the inner shaft member distally upon deployment of the trigger from the first position to the second position, and move the inner shaft member proximally with no displacement of the outer tubular member upon return of the trigger from the second position to the first position. The catheter assembly includes an outer tubular member, an inner shaft member, and a pusher assembly.
-
公开(公告)号:US20160022449A1
公开(公告)日:2016-01-28
申请号:US14876661
申请日:2015-10-06
Applicant: Abbott Cardiovascular Systems, Inc.
Inventor: Florencia Lim , Mary Suh , Barbara Stamberg , Bin Huang
CPC classification number: A61F2/885 , A61F2/04 , A61F2/186 , A61F2/20 , A61F2/844 , A61F2/88 , A61F2/90 , A61F2/95 , A61F2/958 , A61F2/962 , A61F2002/043 , A61F2002/044 , A61F2002/046 , A61F2210/0004 , A61F2210/0076 , A61F2220/0008 , A61F2230/0069 , A61F2230/0091 , A61F2250/0015 , A61F2250/0018 , A61F2250/0028 , A61F2250/0039 , A61F2250/0067 , A61F2250/0098
Abstract: Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.
Abstract translation: 用于治疗哺乳动物患病气管支气管区域的装置和方法。 该装置可以是可以包括缓释材料如具有治疗剂的聚合物基质的支架。 支架可以是生物可吸收的,并且可以并入治疗剂。 治疗方法可以是通过诸如导管组件的递送装置将支架递送到气管支气管区域。
-
公开(公告)号:US20180193605A1
公开(公告)日:2018-07-12
申请号:US15836649
申请日:2017-12-08
Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Inventor: Daniel H. Shumer , Ronald G. Earles , Nianjiong J. Bei , Barbara Stamberg , Daniel C. Simon , Maria Del Rosario Nava
CPC classification number: A61M25/0662 , A61F2/90 , A61F2/966 , A61F2002/9517 , A61M25/005 , A61M25/0068 , A61M25/0136 , A61M2025/015 , A61M2025/0681
Abstract: Catheter assembly for delivering an implant including an outer tubular member, an inner shaft member, and a pusher assembly. The outer tubular member defines an outer tubular member lumen and includes an inner layer, a reinforcement layer, a middle layer, and an outer layer. The inner shaft member is disposed at least partially within the outer tubular member lumen. The inner shaft member includes a proximal inner shaft portion and a distal inner shaft portion, the distal inner shaft portion having a distal end portion. The pusher assembly is coupled to the distal end portion of the distal inner shaft portion. The inner shaft member is configured to move distally and proximally relative the outer tubular member between an initial position and a deployed position.
-
公开(公告)号:US09833342B2
公开(公告)日:2017-12-05
申请号:US14876661
申请日:2015-10-06
Applicant: Abbott Cardiovascular Systems Inc.
Inventor: Florencia Lim , Mary Suh , Barbara Stamberg , Bin Huang
IPC: A61F2/04 , A61F2/88 , A61F2/844 , A61F2/90 , A61F2/958 , A61F2/18 , A61F2/20 , A61F2/95 , A61F2/962
CPC classification number: A61F2/885 , A61F2/04 , A61F2/186 , A61F2/20 , A61F2/844 , A61F2/88 , A61F2/90 , A61F2/95 , A61F2/958 , A61F2/962 , A61F2002/043 , A61F2002/044 , A61F2002/046 , A61F2210/0004 , A61F2210/0076 , A61F2220/0008 , A61F2230/0069 , A61F2230/0091 , A61F2250/0015 , A61F2250/0018 , A61F2250/0028 , A61F2250/0039 , A61F2250/0067 , A61F2250/0098
Abstract: Devices and methods for treating a diseased tracheobronchial region in a mammal. The device can be a stent which can include a sustained-release material such as a polymer matrix with a treatment agent. The stent can be bioabsorbable and a treatment agent can be incorporated therewith. A treatment method can be delivery of a stent to a tracheobronchial region by a delivery device such as a catheter assembly.
-
-
-